Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

CD70-Targeted [<sup>18</sup>F]RCCB6 Immuno-PET/CT Imaging in Patients with Nasopharyngeal Carcinoma: A Proof-of-Concept Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

Trends in cancer imaging.

Trends in cancer·2024
Same author

Design, synthesis and biological evaluation of novel 2-phenyl pyrimidine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors.

MedChemComm·2019
Same author

A systematic analysis of the association between Notch1 expression and the patients with digestive tract cancers.

Biomarkers in medicine·2018
Same author

Occurrence and regression of BK polyomavirus associated carcinoma: a clinical and next-generation sequencing study.

Clinical science (London, England : 1979)·2018
Same author

Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.

Molecular oncology·2018

相关实验视频

Updated: Jan 17, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.6K

CD70-有针对性的无线电静音学:现在和未来

Binyu Shi1, Xinyuan Zhou1, Junjun Zhou2

  • 1Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Seminars in nuclear medicine
|September 19, 2025
PubMed
概括
此摘要是机器生成的。

70分化集群 (CD70) 在癌症中过度表达. 针对CD70的放射性疗法对癌症治疗有前途,解决了当前治疗方法的局限性,如抗体-药物合物和CAR-T细胞.

更多相关视频

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.1K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K

相关实验视频

Last Updated: Jan 17, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.6K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.1K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K

科学领域:

  • 在瘤学瘤学.
  • 放射化学 放射化学是指辐射化学.
  • 免疫治疗是一种免疫疗法.

背景情况:

  • 分化集群70 (CD70) 是TNF超级家族成员,在ccRCC和NPC等恶性瘤中过度表达.
  • CD70作为共刺激受体CD27的连接体起作用.
  • 目前的疗法 (ADC,CAR-T) 面临着诸如耐药性和瘤透率差等挑战.

研究的目的:

  • 审查正常和瘤组织中的CD70表达.
  • 为了突出CD70向的免疫PET/CT成像结果.
  • 讨论治疗性放射性药物对于未来的CD70向辐射疗法开发.

主要方法:

  • 关于CD70表达的文献综述.
  • 对免疫-PET/CT成像的临床试验数据的分析.
  • 对临床前和临床治疗放射性药物的调查.

主要成果:

  • CD70在各种癌症中异常表达.
  • 临床试验显示CD70向免疫PET/CT成像的有希望的结果.
  • 一些治疗性放射性药物正在开发中.

结论:

  • 针对CD70的放射性射剂为当前治疗的局限性提供了潜在的解决方案.
  • 免疫-PET/CT成像证明了临床实用性.
  • 为了临床应用,有必要进一步开发放射性疗法.